TOP STORIES

• BUSINESS Equa, Betanis and More Brands Gird for Generic Entry in 2024; Xarelto Contenders Too?
  January 5, 2024

• BUSINESS After New Year’s Quake, Wholesalers See Challenges in Drug Delivery to North Part of Noto Peninsula
  January 5, 2024

• REGULATORY FY2024 Reform Heralds Shift to Funding Cycle within Drug Budget: MHLW Pharma Director
  December 28, 2023

• TRENDS Top 10 Most-Read PHARMA JAPAN Articles in 2023
  December 28, 2023

• BUSINESS Amylyx Gears Up to Bring New ALS Drug to Japan Market: Country Chief
  December 27, 2023

• REGULATORY Japan Officially Drops Japanese PI Requirement before Global Trial Entry
  December 26, 2023

• REGULATORY (Update) Sawai Slapped with Biz Improvement Order over Rigged Quality Tests
  December 25, 2023

• BUSINESS Sawai Slapped with Biz Improvement Order over Rigged Quality Tests
  December 22, 2023

• ORGANIZATION Reform Package Is “First Step” towards Global Standard, but More Work Remains: JPMA
  December 22, 2023

• REGULATORY Japan to Roll Out New LLP Coverage Rule in October; 18 Billion Yen Saving Eyed for FY2024
  December 21, 2023

• REGULATORY Japan to Cut Drug Prices by 0.97% on Healthcare Cost Basis in FY2024
  December 20, 2023

• REGULATORY Gist of FY2024 Drug Pricing Reform
  December 20, 2023

• COMMENTARY Women’s Health Drugs on a Roll, Further Growth Expected as Public Awareness Rises
  December 19, 2023

• REGULATORY Chuikyo Split on Copay Rate under Elective Care Scheme; Political Decision Likely over 1/2 or 1/4
  December 18, 2023

• BUSINESS Cheplapharm Initiates LLP Acquisitions in Japan, Eyes 10 Asset Takeovers in 2024: Local Head
  December 15, 2023

• REGULATORY Japan OKs FY2024 Tax Reform Outline, “Innovation Box” Scheme Etched
  December 15, 2023

• REGULATORY Leqembi to Cost 2.98 Million Yen per Year, Re-Pricing Might Be Triggered on Patient Upswing
  December 14, 2023

• REGULATORY Shionogi’s Novel Antibiotic Fetroja Gets Fast-Track Listing for Dec. 20
  December 14, 2023

• REGULATORY Leqembi OK’ed for Listing on Dec. 20; Peak Sales Put at 98.6 Billion Yen
  December 13, 2023

• BUSINESS Sobi Eyes Japan Approval of 4 Rare Disease Drugs in 5 Years: Local Chief
  December 12, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 37
• 38
• 39
• 40
• 41
• 42
• 43
• 44
• 45
• …
• Next ›
• 最終 »